PMLS Virtual Series 2021 – Precision Oncology Spring

On Demand Now Click Here

March 30, 2021

Nelson Alexander, PhD

Research Leader, Roche Sequencing Solutions

Steve Anderson, PhD

Chief Science Officer, Covance; Senior Vice President, LabCorp Drug Development

R. Michael Barlow

Senior Advisor, ADVI

Suzanne Belinson, PhD, MPH

Vice President, Commercial Markets, Tempus

Adrian Bot, MD, PhD

Vice President, Translational Medicine, Kite, a Gilead Company

Lisa H. Butterfield, PhD

Vice President, PICI Research and Development, Parker Institute for Cancer Immunotherapy, Adjunct Professor, Microbiology and Immunology, University California San Francisco

Alessandra Cesano, MD, PhD

Chief Medical Officer, ESSA

Jim Christian, MD

Pathologist, Companion Diagnostics, Agilent Technologies

Radu Dobrin, PhD

Executive Director, Head of Bioinformatics Immunology and Immuno-Oncology, Thematic Research Center, Bristol Myers Squibb; Adjunct Associate Professor, Icahn School of Medicine, Mount Sinai School of Medicine

Joel Dudley, PhD, MS

Chief Scientific Officer, Tempus

Maryland Franklin, PhD

Vice President, Enterprise Head of Cell and Gene Therapy, LabCorp Drug Development 

Mark D. Hiatt, MD, MBA, MS

Vice President, Medical Affairs, Guardant Health

Michael Kolodziej, MD

Vice President and Chief Innovation Officer, ADVI Health

Francesco Marincola, MD

Global Head, Research, Kite, a Gilead Company

Amanda Paulovich, MD, PhD

Professor and Aven Foundation, Endowed Chair; Director, CLIA Targeted Proteomic Laboratory Clinical Research Division, Fred Hutchinson Cancer Research Center; Director, Clinical Research Proteomics Platform Brotman Baty, Institute for Precision Medicine; Professor, Department of Medicine / Division of Oncology, University of Washington School of Medicine

Suso Platero, PhD

Vice President, Global Leader Precision Medicine, Head Biomarker Solution Center, Companion Diagnostics, Labcorp Drug Development

Cynthia Pointer, MA

Senior Vice President, Global Payer Strategy & Relations, Invitae

Samra Turajlic, PhD, MBBS, MRCP

Independent Group Leader, Francis Crick Institute; Consultant Medical Oncologist, The Royal Marsden NHS Foundation Trust 

Mark Verardo, PhD

Senior Scientific Program Manager, Companion Diagnostics, Agilent Technologies, Inc